The North America anti-obesity drugs market is poised for significant growth, with an expected CAGR of 9.30% during the forecast period of 2024-2032. This expansion is driven by the rising prevalence of obesity and the increasing demand for effective anti-obesity drugs with fewer side effects. In this blog, we will delve deeply into the key […]
